Development Level

Tbio 6 | 10,625
Tchem 3 | 1,890

IMPC Term

abnormal behavior 1 | 226
abnormal spleen morphology 1 | 36
abnormal vocalization 1 | 21
decreased circulating insulin ... 1 | 75
enlarged spleen 1 | 26
hypoactivity 1 | 89
male infertility 1 | 62

Disease

psoriasis 4 | 6,685
Parkinson's disease 3 | 364
Schizophrenia 3 | 501
diabetes mellitus 3 | 1,663
ovarian cancer 3 | 8,484
Carcinoma 2 | 2,147
Epilepsy 2 | 346
Male infertility 2 | 170
Multiple Sclerosis 2 | 498
Nerve Degeneration 2 | 73
Obesity 2 | 616
interstitial cystitis 2 | 2,299
lung adenocarcinoma 2 | 2,713
lung cancer 2 | 4,466
malignant mesothelioma 2 | 3,162
pituitary cancer 2 | 1,972
posterior fossa group B ependymoma 2 | 1,530
subependymal giant cell astrocytoma 2 | 2,287
Acquired metabolic disease 1 | 267
Alcohol dependence 1 | 107
Alzheimer's disease 1 | 644
Amnestic disorder 1 | 37
Amphetamine-Related Disorders 1 | 74
Amyotrophic Lateral Sclerosis 1 | 431
Anorexia nervosa 1 | 59
Anoxia 1 | 33
Asthma 1 | 349
Attention deficit hyperactivity disorder 1 | 156
Autistic Disorder 1 | 320
Bipolar Disorder 1 | 266
Body Weight 1 | 14
Brain Ischemia 1 | 87
Bulimia nervosa 1 | 15
Cancer 1 | 2,346
Cerebrovascular disease 1 | 231
Child Development Disorders, Pervasive 1 | 55
Cocaine-Related Disorders 1 | 88
Congenital central hypoventilation 1 | 6
Deafness 1 | 18
Deletion 11p13 1 | 3
Dementia 1 | 129
Dental caries 1 | 67
Depressive disorder 1 | 48
Epilepsy, Temporal Lobe 1 | 23
Glaucoma 1 | 134
Gliosis 1 | 16
Gout 1 | 93
Heroin dependence 1 | 30
Huntington's disease 1 | 72
IGA Glomerulonephritis 1 | 454
Inflammation 1 | 109
Intellectual disability 1 | 573
Lupus erythematosus 1 | 80
Major Depressive Disorder 1 | 106
Metabolic syndrome X 1 | 155
Neuropathy 1 | 210
Obesity, Morbid 1 | 6
Opiate dependence 1 | 12
Panic disorder 1 | 55
Parkinson Disease 1 | 102
Psychotic Disorders 1 | 20
Rett syndrome 1 | 18
Schizoaffective disorder 1 | 33
Seizures 1 | 95
Sensorineural hearing loss 1 | 107
Status Epilepticus 1 | 85
Stomach Neoplasms 1 | 282
Substance Withdrawal Syndrome 1 | 52
Substance abuse 1 | 55
Tobacco Use Disorder 1 | 10
Tonic-clonic epilepsy 1 | 47
Toxic encephalopathy 1 | 131
Tularemia 1 | 22
WAGR syndrome 1 | 12
active Crohn's disease 1 | 918
adult high grade glioma 1 | 2,148
astrocytoma 1 | 1,493
atypical teratoid/rhabdoid tumor 1 | 1,095
chronic lymphosyte leukemia 1 | 232
cutaneous lupus erythematosus 1 | 1,056
cystic fibrosis 1 | 1,665
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
hepatocellular carcinoma 1 | 532
interstitial lung disease 1 | 291
invasive ductal carcinoma 1 | 2,950
lung carcinoma 1 | 2,844
mucosa-associated lymphoid tissue lymphoma 1 | 480
nervous system disorder 1 | 53
non-small cell lung cancer 1 | 2,798
obsessive-compulsive disorder 1 | 34
oligodendroglioma 1 | 2,849
osteosarcoma 1 | 7,933
pediatric high grade glioma 1 | 2,712
pilocytic astrocytoma 1 | 3,086
post-traumatic stress disorder 1 | 45
primary Sjogren syndrome 1 | 789
sarcoidosis 1 | 358
substance-related disorder 1 | 105
tuberculosis 1 | 1,557
ulcerative colitis 1 | 2,087

Tissue

Cardiovascular System 9 | 17,958
Digestive Tract 9 | 18,473
Endocrine System 9 | 18,512
Female tissues 9 | 18,647
Liver and Pancreas 9 | 18,136
Male tissues 9 | 17,969
Nervous System 9 | 18,561
Skin and soft tissues 9 | 18,115
Urinary Tract 9 | 18,444
Blood and immune system 8 | 17,995
Respiratory system 8 | 17,484

Target Family

GPCR 4 | 406
Non-IDG 3 | 11,971
Enzyme 1 | 4,146
Ion Channel 1 | 341

Grant Application

7R01DC000766-19 9 | 9
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Taste receptor type 1 member 3 TAS1R3 Tbio GPCR -2.19758 165.4 232
Taste receptor type 1 member 1 TAS1R1 Tbio GPCR -1.71516 50.8 165
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 PLCB2 Tbio Enzyme -2.12352 136.7 95
Metabotropic glutamate receptor 4 GRM4 Tchem GPCR -2.30659 207.4 140
Transient receptor potential cation channel subfamily M member 5 TRPM5 Tchem Ion Channel -1.89870 83.4 103
Guanine nucleotide-binding protein G(t) subunit alpha-3 GNAT3 Tbio Non-IDG -2.24540 179.5 101
Brain-derived neurotrophic factor BDNF Tbio Non-IDG -3.94336 9826.7 594
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.26799 140.7 401
Taste receptor type 1 member 2 TAS1R2 Tchem GPCR -1.97408 92.6 132